Montag & Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $876K | Buy |
2,363
+7
| +0.3% | +$2.47K | 0.04% | 257 |
|
|
2026
Q2 | $846K | Hold |
2,356
| – | – | 0.04% | 268 |
|
|
2026
Q1 | $591K | Hold |
2,356
| – | – | 0.03% | 291 |
|
|
2025
Q4 | $648K | Hold |
2,356
| – | – | 0.03% | 278 |
|
|
2025
Q3 | $618K | Sell |
2,356
-20
| -0.8% | -$4.86K | 0.03% | 288 |
|
|
2025
Q2 | $520K | Sell |
2,376
-24
| -1% | -$5.13K | 0.03% | 302 |
|
|
2025
Q1 | $537K | Hold |
2,400
| – | – | 0.03% | 304 |
|
|
2024
Q4 | $786K | Hold |
2,400
| – | – | 0.04% | 268 |
|
|
2024
Q3 | $720K | Hold |
2,400
| – | – | 0.03% | 281 |
|
|
2024
Q2 | $791K | Hold |
2,400
| – | – | 0.04% | 258 |
|
|
2024
Q1 | $950K | Hold |
2,400
| – | – | 0.05% | 252 |
|
|
2023
Q4 | $845K | Hold |
2,400
| – | – | 0.05% | 245 |
|
|
2023
Q3 | $901K | Hold |
2,400
| – | – | 0.06% | 229 |
|
|
2023
Q2 | $918K | Hold |
2,400
| – | – | 0.06% | 221 |
|
|
2023
Q1 | $832K | Hold |
2,400
| – | – | 0.05% | 231 |
|
|
2022
Q4 | $565K | Hold |
2,400
| – | – | 0.04% | 249 |
|
|
2022
Q3 | $591K | Hold |
2,400
| – | – | 0.04% | 244 |
|
|
2022
Q2 | $726K | Hold |
2,400
| – | – | 0.05% | 235 |
|
|
2022
Q1 | $986K | Hold |
2,400
| – | – | 0.05% | 230 |
|
|
2021
Q4 | $1.13M | Hold |
2,400
| – | – | 0.06% | 224 |
|
|
2021
Q3 | $1.02M | Hold |
2,400
| – | – | 0.05% | 225 |
|
|
2021
Q2 | $862K | Hold |
2,400
| – | – | 0.05% | 240 |
|
|
2021
Q1 | $676K | Hold |
2,400
| – | – | 0.04% | 258 |
|
|
2020
Q4 | $680K | Sell |
2,400
-200
| -8% | -$56.1K | 0.04% | 240 |
|
|
2020
Q3 | $715K | Hold |
2,600
| – | – | 0.06% | 205 |
|
|
2020
Q2 | $591K | Hold |
2,600
| – | – | 0.05% | 212 |
|
|
2020
Q1 | $396K | Hold |
2,600
| – | – | 0.04% | 229 |
|
|
2019
Q4 | $391K | Hold |
2,600
| – | – | 0.03% | 244 |
|
|
2019
Q3 | $369K | Hold |
2,600
| – | – | 0.03% | 243 |
|
|
2019
Q2 | $325K | Sell |
2,600
-600
| -19% | -$70.8K | 0.03% | 255 |
|
|
2019
Q1 | $353K | Hold |
3,200
| – | – | 0.03% | 248 |
|
|
2018
Q4 | $314K | Sell |
3,200
-200
| -6% | -$21.7K | 0.03% | 236 |
|
|
2018
Q3 | $420K | Hold |
3,400
| – | – | 0.04% | 252 |
|
|
2018
Q2 | $338K | Hold |
3,400
| – | – | 0.03% | 237 |
|
|
2018
Q1 | $300K | Hold |
3,400
| – | – | 0.03% | 243 |
|
|
2017
Q4 | $335K | Hold |
3,400
| – | – | 0.03% | 236 |
|
|
2017
Q3 | $327K | Hold |
3,400
| – | – | 0.04% | 212 |
|
|
2017
Q2 | $321K | Hold |
3,400
| – | – | 0.04% | 207 |
|
|
2017
Q1 | $277K | Hold |
3,400
| – | – | 0.03% | 216 |
|
|
2016
Q4 | $288K | Hold |
3,400
| – | – | 0.03% | 212 |
|
|
2016
Q3 | $253K | Hold |
3,400
| – | – | 0.03% | 222 |
|
|
2016
Q2 | $258K | Hold |
3,400
| – | – | 0.03% | 217 |
|
|
2016
Q1 | $236K | Hold |
3,400
| – | – | 0.03% | 217 |
|
|
2015
Q4 | $205K | Sell |
3,400
-1,100
| -24% | -$66.2K | 0.03% | 228 |
|
|
2015
Q3 | $244K | Hold |
4,500
| – | – | 0.04% | 217 |
|
|
2015
Q2 | $261K | Hold |
4,500
| – | – | 0.04% | 221 |
|
|
2015
Q1 | $271K | Hold |
4,500
| – | – | 0.04% | 228 |
|
|
2014
Q4 | $240K | Hold |
4,500
| – | – | 0.04% | 224 |
|
|
2014
Q3 | $201K | Buy |
+4,500
| New | +$191K | 0.03% | 233 |
|
|
2014
Q1 | – | Sell |
-4,500
| Closed | -$221K | – | 243 |
|
|
2013
Q4 | $221K | Buy |
+4,500
| New | +$211K | 0.04% | 217 |
|
Other funds holding WST
Montag & Associates's WST Position: Q3 2026 in Review
Montag & Associates increased its West Pharmaceutical (WST) stake by 0.3% in Q3 2026, buying an estimated $2.47K and bringing the position to 2,363 shares worth $876K. The position accounts for 0.04% of the portfolio, ranked #257.
Montag & Associates first reported a position in WST in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.13M in Q4 2021. 515 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Montag & Associates held 2,363 shares of West Pharmaceutical worth $876K as of Q3 2026.
- Montag & Associates bought 7 West Pharmaceutical shares in Q3 2026, an estimated $2.47K.
- West Pharmaceutical made up 0.04% of Montag & Associates's portfolio in Q3 2026, its #257 holding.
- Montag & Associates first reported a position in West Pharmaceutical in Q4 2013 and has held it in 50 quarters since.
- Montag & Associates's West Pharmaceutical position peaked at $1.13M in Q4 2021.
- 515 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Montag & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.